C-reactive protein as a prognostic marker FOR mCRPC

BJU Int. 2012 Dec;110(11 Pt B):E469. doi: 10.1111/j.1464-410X.2012.11156.x. Epub 2012 Apr 23.

Authors

Michael R Abern, Emma H Allott, Stephen J Freedland

PMID: 22519959
DOI: 10.1111/j.1464-410X.2012.11156.x

No abstract available

Publication types

Editorial
Comment

MeSH terms

C-Reactive Protein / metabolism*
Docetaxel
Humans
Male
Orchiectomy*
Prostatic Neoplasms / blood*
Taxoids / administration & dosage*

Substances

Taxoids
Docetaxel
C-Reactive Protein